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1Department of Biochemistry & Biophysics, University of Rochester Medical Center, Rochester, New YorkABSTRACT G protein-coupled receptors are vital membrane proteins that allosterically transduce biomolecular signals across
the cell membrane. However, the process by which ligand binding induces protein conformation changes is not well understood
biophysically. Rhodopsin, the mammalian dim-light receptor, is a unique test case for understanding these processes because
of its switch-like activity; the ligand, retinal, is bound throughout the activation cycle, switching from inverse agonist to agonist
after absorbing a photon. By contrast, the ligand-free opsin is outside the activation cycle and may behave differently. We find
that retinal influences rhodopsin dynamics using an ensemble of all-atom molecular dynamics simulations that in aggregate
contain 100 ms of sampling. Active retinal destabilizes the inactive state of the receptor, whereas the active ensemble was
more structurally homogenous. By contrast, simulations of an active-like receptor without retinal present were much more het-
erogeneous than those containing retinal. These results suggest allosteric processes are more complicated than a ligand
inducing protein conformational changes or simply capturing a shifted ensemble as outlined in classic models of allostery.INTRODUCTIONG protein-coupled receptors (GPCRs) are integral mem-
brane proteins that serve wide-ranging functions from olfac-
tion (1,2) to modulating cardiac response (3). There are
more than 800 GPCRs in humans (4), and they are targeted
by a remarkable number of drugs (5–7). These proteins
transmit signals across the cell membrane using an allosteric
mechanism; ligands binding in the canonical orthosteric site
modulate receptor conformations such that G proteins inside
the cell can bind the cytoplasmic face of the GPCR.
Rhodopsin, the mammalian dim-light receptor, was the first
GPCR to be reported at high resolution (8) and has served as
a useful model for understanding the dynamics and function
of other proteins. However, the process by which ligand
conformational change is communicated to the protein’s
active site remains poorly understood despite vast biochem-
ical and biophysical efforts (9,10). Some hypotheses suggest
that highly conserved motifs in the protein may serve as
functional microswitches, making concerted transitions
upon ligand binding (10–17), but the details of any such pro-
cess remain elusive (15,18,19).
Early discussions of GPCR dynamics were generally
framed in terms of two states (active and inactive) connected
by a single path. Although this view has yielded to a more
complex understanding of GPCR dynamics, a simplified sin-
gle pathway description is still prevalent, despite mounting
evidence that suggests this idea is flawed (20–22). TheSubmitted February 23, 2015, and accepted for publication June 19, 2015.
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0006-3495/15/08/0608/10complexity of GPCR activation is only beginning to be
understood (20–24). Experimental evidence suggests that
multiple states and multiple activation pathways may exist
(10,20,21,25,26). Additionally, GPCR activity may be
modulated by external factors, such as dimerization (27),
membrane environment (28–31), and pH (16,32–34). Even
ligands that evoke a functionally similar response may
have a varied impact on specific residues (21). For example,
the b2 adrenergic receptor (b2AR) can sample a diverse range
of conformational states with variable populations and life-
time shifts that depend on the environment and presence of
ligands (25).
The subtlety of GPCRs’ functional dynamics presents a
major opportunity for contribution from computational
methods. Although experimental techniques can probe a
small subset of interesting degrees of freedom, molecular
dynamics (MD) simulations capture atomistic-resolution
details of the system. As a result, MD simulations can unam-
biguously characterize the structural ensemble accessible to
GPCRs under different conditions, without the perturbations
of adding probes such as fluorescent dyes.
However, all-atom simulations are so computationally
costly that supercomputers or specialized hardware are often
needed, and even then acquiring sufficient statistical sampling
is a serious problem. This problem is often underestimated,
because even degrees of freedom that interconvert rapidly
can be linked to the much slower dynamics of the entire
protein (35–37). Enhanced sampling methods can improve
the situation, but most advanced methods require the choice
of an informative reaction coordinate, which can be very
difficult to obtain. On the other hand simplified models can
be quite useful (19), but often lack the resolution to answer
very specific scientific questions. Because of the largehttp://dx.doi.org/10.1016/j.bpj.2015.06.046
TABLE 1 Simulation details
System PDB ID Notes Simulation Time (ns)
Dark opsin 1U19 retinal removed 1 z 3,000, 5 z 4,000
Opsin 3CAP 3 z 4,000, 3 z 4,200
Meta-I Meta-I (from 45) 6 z 4,800
Meta-II 3PXO 3 z 4,000, 3 z 4,200
Total z 101,000 ns
An exhaustive list is available in Table S1.
Retinal Alters Rhodopsin Dynamics 609datasets and their biomedical relevance, understanding allo-
stery in the activation of GPCRs is a topic of intense interest.
In this study, we use rhodopsin as a platform to better un-
derstand allostery, exploring the effects of the presence or
absence of retinal on its conformational ensemble.Rhodopsin
is unique among GPCRs because of its switch-like behavior;
retinal undergoes an 11-cis to all-trans bond isomerization
upon absorption of a photon, making an in situ switch from
inverse agonist to agonist and allowing protein activation to
proceed. Rhodopsin, togetherwith its apo-form, opsin,makes
an effective case for ligand effects on protein dynamics
because, unlike most ligand-binding proteins, the apo form
lies outside of this functional cycle (Fig. 1).
Crystal structures of opsin show a very active-like confor-
mation (38,39), in distinct contrast to functional experi-
ments showing that opsin does not efficiently induce
downstream G protein signaling (40). To rationalize this
apparent contradiction, we used MD simulations to produce
ensembles of conformations for both opsin and rhodopsin
using active-like and inactive-like starting structures. Spe-
cifically, we simulated the Metarhodopsin-I (Meta-I) and
Metarhodopsin-II (Meta-II) states of rhodopsin, and opsin
in both its active-like crystal structure and a hypothesized
inactive-like dark opsin (see Fig. 1 and Table 1). Our results
suggest that opsin is able to sample a superset of those con-
formations accessible to Meta-II rhodopsin. Remarkably,
these simulations capture ligand-dependent changes to theFIGURE 1 Rhodopsin activation cycle. 11-cis retinal is prebound in the
inactive dark-state. Absorption of a photon causes 11-cis to all-trans photo-
isomerization, and changes retinal from an inverse agonist to agonist. Acti-
vation then proceeds through several trappable nonequilibrium
intermediates (not all shown) before reaching Metarhodopsin-I (Meta-I).
Meta-I exists in equilibrium with the fully active Metarhodopsin-II
(Meta-II). The retinal-rhodopsin bond is cleaved and retinal is able to leave,
resulting in the apo-protein opsin. Upon rebinding of an 11-cis retinal this
cycle is then ready to be repeated. To see this figure in color, go online.structural ensemble. In Meta-I simulations, both the ligand
and the protein are more dynamic.
In the context of allostery, the results are quite nuanced;
whereas an active-like apo-protein is more conformationally
heterogeneous, an inactive protein bound to activating
ligand is destabilized. In rhodopsin, it appears that the
ligand has a role beyond that outlined by the conformational
equilibrium model of allostery: it can stabilize one ensemble
of conformations and destabilize another, as suggested by
more recent allosteric hypotheses (41–44).MATERIALS AND METHODS
Simulation details
Four different protein starting structureswere used in the current study. Three
were obtained from x-ray crystal structure data; opsin andMeta-II were used
as is, whereas dark opsin was built by removing the retinal from a crystal
structure of dark-state rhodopsin. The fourth (Meta-I) was taken from the
final coordinates of the complex-counterion simulation conducted in a previ-
ous study (45–47); we assert that this structure resembles the Meta-I state of
the protein based on the behavior of the Schiff base, as well as the match be-
tween the theoretical NMR spectra calculated from this trajectory and exper-
iment (46). Six independent systems were then built for each structure, for
a total of 24 trajectories (see Table 1). Each structure was embedded in a
randomized lipid bilayer containing 123 SDPE (1-stearoyl-2-docosahexae-
noyl-phosphatidylethanolamine) molecules, 8200 waters, and 100 mM
NaCl (beyond that needed to neutralize the system). SDPE lipids were
chosen because polyunsaturated fatty acids and phosphatidylethanolamine
headgroups were experimentally shown to favor the active Meta-II confor-
mation (28–31,48,49). We also simulated low-pH conditions, protonating
Glu1343.49 and Glu181EL2. This decision was based on the work of multiple
investigators (16,32–34,50,51), which suggested such conditions favor acti-
vation. Six replicates were run for each protein starting structure, ranging
from 3 to 4 ms each. Each replicate for a given starting state was assembled
using the same protein structure, but the lipid and water coordinates were
generated independently using a previously published protocol (52).
The system was simulated in the NPgTensemble using the CHARMM36
lipid parameters (53) and CHARMM22 protein parameters (54) with
CMAP corrections (55,56). These simulations were begun before SDPE
was specifically parametrized (see 57), and we found that a lateral tension
of 30 dyn/cm was needed to obtain the correct area per lipid (data not
shown). Retinal parameters were obtained from Scott Feller (see 58).
This systemwas then subjected toMD using NAMD 2.8 (59), with the Ve-
locity Verlet integrator and a 2 fs timestep (60). Bonds to hydrogen were con-
strained using theRATTLE algorithm (61). The Langevin piston barostat was
combinedwithLangevin dynamics to produce the correct isothermal-isobaric
ensemble at 310 K (62,63). The nonbonded cutoff was set to 10 A˚, whereas
long-range electrostatics were calculated using smooth particle-mesh Ewald
summation (64) with a 75  75  96 cubic grid (z 1 A˚/grid point). These
simulations were run on the University of Rochester’s BlueGene/P and Blue-
Gene/Q computers. The trajectory details can be found in Table 1.Biophysical Journal 109(3) 608–617
610 Leioatts et al.Simulation analysis
All simulation analyses were implemented in LOOS (version 2.0.5, loos.
sourceforge.net), an open-source simulation development library main-
tained by the Grossfield lab (65). Images were rendered using PyMol
(version 1.6, www.pymol.org), and data was plotted with gnuplot (version
4.6, www.gnuplot.info).RESULTS
We computed an ensemble of conformations that represent
different functional states of rhodopsin, finding that retinal
plays an important role in modulating the protein’s behavior.
Somewhat surprisingly, the ligand’s interaction with the
protein was quite promiscuous. These results provide evi-
dence that the rhodopsin system behaves in a manner that
cannot be explained by the classic allosteric model of
conformational selection (66).Dynamics of experimentally interesting degrees
of freedom
Retinal
To understand how retinal impacts rhodopsin’s conforma-
tional ensemble, we first investigated how the protein’s
starting state correlated with ligand dynamics. Our previousBiophysical Journal 109(3) 608–617work showed that after the 11-cis to all-trans isomerization
retinal became more flexible (46,47,67). Here we extend
that view to understand how all-trans retinal behaves in
the active Meta-II state versus the preactive Meta-I state
(Fig. 2) using the new ensemble of simulations outlined
in Table 1.
Previous efforts by several labs have shown that retinal
makes state-specific protein-ligand interactions (68–72).
We monitored retinal using three regions of the ligand
equivalent to those identified by Brown and coworkers,
the orientations of the C5-, C9-, and C13-methyl groups
(46,47,73–76). In this analysis, the vectors denoted by the
three arrows in Fig. 2 b (see caption for details) were
compared with the membrane normal (black vector in
Fig. 2 a) using a simple dot product. (Retinal orientations
for individual trajectories are available in Figs. S1–S6 in
the Supporting Material.)
The ligand-binding pocket
Because the orientation of retinal’s b-ionone ring was
quite varied whereas the dynamics closer to the covalently
bound Lys2967.43 depended on the protein’s state, it is
logical to examine the behavior of nearby aromatic side-
chains that interact with retinal, coupling it to the rest
of the protein. These particularly include Phe2616.44,FIGURE 2 Retinal dynamics distinguish the
Meta-I and Meta-II ensembles. (a) Illustration
showing rhodopsin in a lipid bilayer. The protein
is shown as a rainbow colored cartoon with the
N-terminus colored blue. Lipids are shown in a
black/white ball-and-stick representation (note
several lipids are removed for clarity). The black
arrow denotes the membrane normal. The inset
shows a close-up view of retinal (purple ball-
and-sticks) in the binding pocket. It is covalently
attached to Lys2967.43 (orange) by a Schiff-
base linked nitrogen. (b) Retinal orientations. A
morphed retinal is shown colored as in (a). Its
orientation was monitored using the three vectors
illustrated by yellow, gray, and green arrows. Spe-
cifically, we computed the dot-product between a
vector drawn from either: the C1–C5 atoms
(yellow), the C9–C19 atoms (gray), or the C13–
C20 atoms (green) and the membrane normal
(black arrow in a). This angle was histogrammed
over the entire Meta-I (blue data) or Meta-II (red
data) ensemble of trajectories. The average histo-
grams are shown below, with error bars represent-
ing the standard error. To see this figure in color, go
online.
Retinal Alters Rhodopsin Dynamics 611Trp2656.48, and Tyr2686.51, the rotamer toggle switch res-
idues. Phe2616.44 shows no discernible trend, but in the
Meta-II ensemble the gauche- rotamer had a much smaller
population than in the other simulations (Fig. 3 b), which
may be an impact of the stable ligand conformation (see
the previous section). In Trp2656.48 and Tyr2686.51 the
active-like ensembles (opsin and Meta-II) showed a
different preferred orientation to the inactive-like ensem-
bles (dark opsin and Meta-I). Trp2656.48 (Fig. 3 b, middle)
showed a stronger preference for the gauche- rotamer in
opsin and Meta-II, whereas dark opsin and Meta-I occu-
pied a primarily trans rotamer. As we will show below
(see also Fig. 4) this same population ordering—dark
opsin, Meta-I, opsin, Meta-II—was seen in measures of
whole-protein activity. Tyr2686.51 (Fig. 3 b, bottom) also
showed a distinction between active-like and inactive-
like ensembles.
Cytoplasmic regions
We also monitored the dynamics of two conserved cyto-
plasmic motifs: the ionic lock (a salt bridge between
Glu2476.30 and Arg1353.50) and the NPxxY sequence in
TM7 (Fig. 3, c and d). Interresidue distances for the ionic
lock are plotted as a function of simulation time in
Fig. S7. There was only a single transition in this coordinate,
in one of the opsin simulations, although there was one
short-lived opening event in one of the dark opsin runs. If
we monitor the ionic lock distance versus the NPxxY motif
root mean square deviation (RMSD) from the inactive




edifferent. We found that the NPxxY region is quite flexible,
especially in the Meta-I ensemble, even though there are
no transitions in the ionic lock (Fig. 3 e). By contrast, the
lock flickers in dark opsin simulations, but the NPxxY
region is not as flexible. In opsin, there was a single lock
closing event, which did coincide with a decrease in NPxxY
RMSD, but the Meta-II ensemble produced NPxxY confor-
mations just as close to the inactive structure even though
the lock never transitioned.Whole protein dynamics reveal heterogeneity in
opsin and Meta-I
We found that probing only experimentally motivated de-
grees of freedom gave an incomplete picture of rhodopsin’s
dynamics and thus also explored protein dynamics using
data-derived methods. First, we introduced a reaction coor-
dinate based on the interresidue contacts formed and broken
in our simulations. Instead of analyzing all contacts, we
limit this analysis only to those contacts present in either
the inactive and active crystal structures, but not both.
A smooth tanh function was used to define connectivity









where rc is a switching distance of 8 A˚ and rij is the distance
between the two side chains. The contact values were then
summed and normalized such that a value of 1 is obtainedFIGURE 3 Dynamics of biologically distin-
guished structural motifs. (Center) Rhodopsin is
shown as a rainbow cartoon embedded in a lipid
bilayer. The bottom view shows the protein’s cyto-
plasmic face. (a) Illustration showing retinal (white
spheres) in its binding pocket and rotamer toggle
residues: Phe2616.44 (pale yellow), Trp2656.48
(pale violet), and Tyr2686.51 (dark red). (b) Histo-
grams of the population of c1 torsion angles for
each of the three toggle switch residues. Data is
colored by the simulation ensemble. (Note: a
version of this figure with error bars is depicted in
Fig. S8.) (c) Close-up view of the NPxxY motif.
(d) The ionic lock. Arg1353.50 and Glu2476.30 are
shown forming a salt bridge (left) as in the inactive
crystal structure (PDB ID: 1U19) or in an open
conformation (right) as in the active crystal struc-
ture (PDB ID: 3PXO). (e) NPxxY motif versus
ionic lock dynamics. The NPxxY RMSD from the
inactive crystal structure (y axis) is shown versus
the ionic lock distance (x axis). Every frame
(sampled at a rate of 1 ns) is shown colored ac-
cording to ensemble. To see this figure in color,
go online.
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FIGURE 4 Contact-based reaction coordinate shows opsin and Meta-I
ensembles are more heterogeneous. The average transition is shown for
all 24 trajectories as a function of simulation time. This value is calculated
using Eq. 1, where contacts are computed on a per-residue basis using side-
chain centers of mass. Data is averaged over the six independent simula-
tions in each of the four ensembles with error bars representing the standard
deviation. The single dark-state simulation from Grossfield et al. (45) is




FIGURE 5 Ensemble-based principal component analysis was con-
ducted on the transmembrane a-carbons of all 24 trajectories in aggregate,
so the results depict how each simulation is projected onto the same basis
set. Each of the trajectories used in this analysis is labeled according to
its ensemble as shown in the key at the bottom of the figure. (a) Average
projection of trajectory time course onto principal component one. Simula-
tions are grouped by the four starting structures outlined in Table 1. Curves
show the average across all six trajectories for each ensemble, with error
bars showing the average of the standard deviations in each dataset, to
emphasize which trajectories are more heterogeneous. (b and c) Projection
onto the first two principal components. Each data point represents a struc-
ture from the ensemble of trajectories (sampled at 1 ns a piece) and colored
according to ensemble. The x axis represents displacement along PC1, the
y axis displacement along PC2. (b) Each ensemble is shown separately on
the same scale. (c) Merged view of the result from (b). Opacity of the points
shows the time evolution of each independent trajectory. To see this figure
in color, go online.
612 Leioatts et al.when the contacts are exactly those found in the inactive
crystal, and 0 when they are those found in the active
structure. This quantity, the transition value, was monitored
as a function of simulation time, t, as depicted in Fig. 4.
Because of thermal fluctuations, values near 1 or 0 are rarely
sampled.
Fig. 4 contains data from a previously published (45) con-
trol simulation of inactive rhodopsin (black curve); because
11-cis retinal totally deactivates rhodopsin, this serves as
a base level of conformational heterogeneity. By the time
this control system was equilibrated it had already made
an z 0.3 transition along the reaction coordinate (from
1.0 to 0.7) simply because of thermal fluctuations.
Considering the two active-like starting structures—opsin
and Meta-II—opsin appears to progress to a slightly more
inactive-like state than Meta-II, only in part because of the
single trajectory that underwent a deactivation event. This
makes sense given that a range of experimental evidence sug-
gests that opsin shows much lower activity than Meta-II
rhodopsin.
Opsin samples a superset of Meta-II conformations
To better understand the conformational heterogeneity in
our simulations, we next calculated the principal compo-
nents of motion using only the transmembrane a-carbons.
(Fig. 5). For this calculation we grouped all 24 trajectories
together, so that the resulting eigenvectors form a common
basis set describing the fluctuations across all four ensem-
bles. Fig. 5 a shows the average projection of each simula-
tion onto the first principal component. Each curve depictsBiophysical Journal 109(3) 608–617
FIGURE 6 Mapping principal components back onto structures. (a)
Illustration showing PC1. The first eigenvector is projected back onto a
cartoon representation of the average structure from all 24 simulations.
Rhodopsin is shown as a rainbow, with blue indicating the N-terminus.
Black sticks project from the ca position in the direction of the first prin-
cipal component, with a length proportional to their contribution to the
motion. Transparent overlays show the Meta-II (78) (dark red) and dark-
state (72) (marine) crystal structures. The top view shows rhodopsin in the
plane of the membrane, the bottom view is normal to the membrane from
the cytoplasmic side. (b) As in (a), except with sticks representing the second
principal component of motion. To see this figure in color, go online.
Retinal Alters Rhodopsin Dynamics 613the average of all six trajectories from the four different
starting states.
Principal component 1 (Fig. 5 a) distinguished the active
and inactive structures: the active-like opsin and Meta-II
ensembles have similar average displacements, as do the
inactive-like dark opsin and Meta-I. However, the opsin
ensemble had a much larger standard deviation than
Meta-II, indicating more disparity of structures in that data-
set, driven at least in part by the simulation where the ionic
lock closed. Along the same lines, dark opsin shows smaller
fluctuations in this dimension than Meta-I, again consistent
with Fig. 4. Meta-II trajectories also sampled a narrower
range of conformations. In Fig. 5, b and c we expanded
this analysis to the first two principal components. Every
frame (sample rate ¼ 1 ns) from the 24 simulations was
plotted. Opsin (Fig. 5 b, lower left) sampled a superset of
those conformations accessible to the fully active Meta-II
(Fig. 5 b, lower right). Moreover, opsin had more dynamic
range in PC1 and PC2 and some structures produced by
opsin simulations overlapped with the inactive ensembles
(Meta-I and dark opsin). Meta-I was also very dynamic—
it accounted for the largest displacement in PC2, and pro-
duced conformations with displacements that adjoin the
active-like ensembles. These results are also corroborated
by projections onto the first three principal components
(see Movie S1).
Although this analysis provided an intuitive way to under-
stand the structural variation in our dataset, the biological
meaning of these reduced coordinates was less clear. There-
fore, we mapped the first two principal component eigen-
vectors back onto the structures themselves (Fig. 6). The
dark-state (marine) and Meta-II (dark red) crystal structures
are also shown for reference. The largest contribution to
PC1 (Fig. 6 a) comes from the cytoplasmic portion of
TM5 and TM6. The vectors around TM6 in particular
appear to connect the inactive and active structures. By
contrast, PC2 (Fig. 6 b) captures motion reminiscent of
TM5 unwinding and the large variation in the NPxxY
region. In contrast to b2 AR, the motions of TM6 and the
NPxxY region may be decoupled in rhodopsin activation.
Opsin and Meta-I explore conformations more rapidly
Visual inspection of Movie S1 shows that opsin and Meta-I
were not only filling larger volumes in conformational
space, but at the end of the simulations they were still
spreading out, whereas dark opsin and Meta-II were more
contained. This would suggest that our opsin and Meta-I
simulations were not only more heterogeneous, but were
also expanding more rapidly. To better understand this sub-
tle difference, we used a structural clustering algorithm
(Fig. 7), where the simulations were separated into k clusters
based on RMSD of the transmembrane a-carbons. Results
are shown using k ¼ 10 clusters, but were robust when
varying k from 5 to 50. We included our whole dataset of
24 trajectories, with two additional previously publishedsimulations: the dark-state simulation and a transition simu-
lation covering dark-state to Meta-I (referred to as the com-
plex counterion trajectory in Grossfield et al. (45)).
Fig. 7 a shows a histogram of the population of each
cluster, color-coded by the starting protein structure. Once
again, this analysis identifies opsin and Meta-I as very het-
erogeneous. Structures produced by the opsin simulations
(orange) occupy seven different bins, and those produced
in the Meta-I simulations (blue) occupy five bins. By
contrast, Meta-II and dark opsin occupy four and two clus-
ters, respectively; they produced a more homogeneous
ensemble of structures.
The time course of these conformational changes was
even more revealing (Fig. 7, b–e). Here cluster population
is shown as a function of simulation time, with each of
the four ensembles depicted separately, but summed over
the six replicas of each system. Because all simulations
within an ensemble had the same starting structure, we
expect them to occupy the same initial cluster and diverge
from there, as can be seen in all four panels. Dark opsin
(Fig. 7 b) occupied three bins, (nominally clusters 0, 1,
and 2). The simulations began producing structures
that fell into cluster 0, but very quickly there was someBiophysical Journal 109(3) 608–617
FIGURE 7 Structure-based clustering reveals a
heterogeneity of substates in opsin and Meta-I. A
k-means clustering algorithm based on RMSD
was used on all 24 simulations in aggregate plus
the dark-state and complex counterion simulations
from Grossfield et al. (45). (a) Histogram showing
the raw counts for each cluster. Data is colored ac-
cording to starting structure. Cluster numbering is
arbitrary. (b–e) Time course of clustering data for
all six simulations with the same starting structure.
The color intensity represents population, which is
plotted for each cluster (y axis) as a function of
simulation time (x axis). The data is averaged
in 50 ns windows across all six trajectories for
(b) dark opsin, (c) Meta-I, (d) opsin, and (e)
Meta-II. To see this figure in color, go online.
614 Leioatts et al.divergence into clusters 1 and 2. This population distribu-
tion then persisted for the first 1500 ns, until cluster 2
became unoccupied. However, instead of diverging further,
the population of cluster 0 increased during the second half
of the simulation time. In other words, the dark opsin
ensemble was sampling structures more similar to its start-
ing conformation after 1500 ns of simulation. We also saw
that Meta-I and opsin were not only occupying more clus-
ters, but their original clusters (numbers 3 and 8, respec-
tively) were diminished at the end of the simulations
(Fig. 7, c and d) and these trajectories continued to diverge.
Meta-II (Fig. 7 e) simulations occupied three clusters, but
the vast majority of this data fell into a single cluster,
whereas the other two were only occupied transiently.
This result suggests the more heterogeneous ensembles
are continuing to diverge more rapidly, even after 3 to
4 ms of sampling.DISCUSSION
The results presented in this study indicate that retinal has
a dramatic and complex influence on the conformational
ensemble available to rhodopsin. All-trans retinal serves
both to stabilize the active conformational ensemble and
destabilize the inactive ensemble. Alternatively, without
retinal opsin ismore structurally diverse, even spontaneously
sampling inactive-like structures (Figs. 3 e, 5 c, and 7 a).Biophysical Journal 109(3) 608–617In both retinal-containing ensembles, the b-ionone ring
was quite dynamic (Fig. 2 b, left); this flexibility can also
be seen in the individual trajectories (Figs. S1–S4). However,
there are differences between Meta-I and Meta-II closer to
the Schiff-base linkage. The C9-methyl (Fig. 2 b, middle)
and C13-methyl (Fig. 2 b, right) adopted multiple different
configurations in Meta-I simulations (see Fig. S5). An anal-
ogous result was observed by Lee and Lyman in the A2A
adenosine receptor, suggesting that GPCR ligands are quite
promiscuous within the binding pocket (79). We also
observed heterogeneity closer to Lys2967.43 in previous sim-
ulations of Meta-I formation (47). However, in the Meta-II
ensemble, the C13-methyl tended to point toward the cyto-
plasm (cos ¼ 1) as seen in Figs. 2 b and S6. The portion
of retinal linked to Lys2967.43 was less flexible in theMeta-II
ensemble of simulations compared with Meta-I. This ligand
stability correlated with the overall protein dynamics in the
Meta-II ensemble, whereas Meta-I sampled a more diverse
set of structures.
Interestingly, the residues comprising the rotamer toggle
switch did not show a preference that segregates active-like
and inactive-like ensembles; rather, multiple rotamer angles
were sampled without leading to large-scale conformation
changes in TM6. Although these highly conserved residues
are implicated in GPCR activation, our simulations are
consistent with recent work that casts doubt on any simplistic
mechanism describing their action (10–18,71,77,80). We
Retinal Alters Rhodopsin Dynamics 615speculate that these residues may act through clutches as in
a car’s transmission: when engaged, the clutches link these
residues to a larger network that facilitates conformational
change. When not engaged—the far more probable sce-
nario from our limited data—rotameric transitions are not
coupled to large-scale motions. Our present dataset is not
sufficient to support this idea beyond speculation. Future
work will be required to substantiate this claim and deter-
mine what precisely these clutches are, and how they are
engaged.
The simulations presented here represents one of the
larger collections of all-atom GPCR trajectories published,
but it is clear these simulations have not converged to the
full ensemble of conformations accessible to rhodopsin;
the two opsin setups are chemically identical, as are the
Meta-II and Meta-I simulations, and yet the different start-
ing protein structures are enough to yield dramatically
different ensembles. In essence, the simulations are long
enough to sample well within a given state, but not long
enough to explore transitions between states in a statistically
significant way. This means that our efforts are more pro-
ductively focused on understanding the dynamics of each
state, so that we can connect the differences between states
to protein function. The results suggest that the presence of
retinal stabilizes the protein in a more active-like ensemble
of conformations, which may be because of the specific
retinal orientation discussed earlier (Figs. 2 b and S6, b
and c). In effect, all-trans retinal may discourage rhodopsin
from taking inactive structures—selecting for these active
conformations. By contrast, Meta-I is consistently more
active-like than dark opsin. Because all-trans retinal appears
in situ within the binding pocket, it may serve a dual role,
destabilizing the Meta-I ensemble as well as stabilizing
Meta-II, playing a role similar to that suggested previously
(41,42).
This is evident in the heterogeneity of Meta-I and the rela-
tive homogeneity of Meta-II (Figs. 4, 5, and 7). The opposite
trend was seen when retinal was absent: inactive-like con-
formations were preferred. Interestingly, opsin was able to
transition from an active-like conformation to an inactive
one. Rather than thinking in terms of retinal inducing this
conformational change or selecting/capturing a preferred
conformation, we suggest thinking in terms of the underly-
ing energy landscape. The presence (and state) of retinal is
simply shifting the free energy minima. After all, we know
that all conformations are possible—some just have vanish-
ingly small probabilities.
From this data, it appears the ligand is not only chang-
ing the conformational ensemble accessible to the protein,
but also how rapidly the protein explores the free energy
landscape. It may be that ligand presence is altering the
landscape, in this case effectively smoothing barriers
(or increasing the attempt rate) to activation. This result
argues in favor of the more recent views of allostery
(e.g., 41–44).CONCLUSIONS
Our results suggest that retinal has a substantial impact on
rhodopsin dynamics—even this functionally switch-like
protein is quite plastic at the molecular level. This is consis-
tent with single-molecule experiments on b2AR, suggesting
that there are diverse states sampled along the activation-
deactivation continuum (21,25).
Rather than thinking in terms of a discrete set of sub-
states, the emerging view is that proteins are more dy-
namic and sample a diverse ensemble of configurations.
Although some of the biologically important motifs stud-
ied coincided with overall protein dynamics, others did
not appear to correlate with any functionally related
motion. One analogy to describe how allosteric informa-
tion might be communicated is to think of these regions
as a series of gears that are connected by (dis)engageable
clutches. In this view, a motif can move freely—sampling
many conformations without affecting the functional
state—so long as the clutch connecting it to the protein
at large is disengaged. Once engaged, that same motif
has a vital impact on the overall structure of the protein.
In this view, the purpose of the ligand would be to influ-
ence the position of these clutches. Understanding how
these gears interconnect in the context of the protein’s
free energy landscape will be a topic for much future
work. This will need to be understood in the realm of sta-
tistical mechanics, going beyond the early phenomenolog-
ical models of allostery. However, the picture of allostery
is more complicated than solely selecting one conforma-
tion or directly inducing a conformation switch; the ligand
can serve both functions.SUPPORTING MATERIAL
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